CD73 on T cells orchestrates cardiac wound healing after myocardial infarction by purinergic metabolic reprogramming

Circulation

Volumn 136, Issue 3, 2017, Pages 297-313

  Borg, Nadine ^a   Alter, Christina ^a   Görldt, Nicole ^a   Jacoby, Christoph ^a   Ding, Zhaoping ^a   Steckel, Bodo ^a   Quast, Christine ^a   Bönner, Florian ^a   Friebe, Daniela ^a   Temme, Sebastian ^a   Flögel, Ulrich ^a   Schrader, Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

cell signaling signal transduction; fibrosis; inflammation; ischemia; metabolism

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5' NUCLEOTIDASE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BAY 60 6583; CD157 ANTIGEN; CD38 ANTIGEN; CD39 ANTIGEN; CONNEXIN 37; CONNEXIN 43; CYCLIC AMP; ECTO NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; ECTO NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GAMMA INTERFERON; INTERLEUKIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE; PANNEXIN 1; PROTEIN; PSB 603; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART INFARCTION; HEART TISSUE; HYDROLYSIS; LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; UPREGULATION; WOUND HEALING; ANIMAL; CELL MOTION; FEMALE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NUCLEAR REPROGRAMMING; PHYSIOLOGY; TRANSGENIC MOUSE;

5'-NUCLEOTIDASE; ANIMALS; CELL MOVEMENT; CELLULAR REPROGRAMMING; FEMALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; T-LYMPHOCYTES; WOUND HEALING;

EID: 85019690627     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.023365     Document Type: Article

References (47)

1. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, Flaker GC, Braunwald E, Pfeffer MA; CARE Study. Predictors of late development of heart failure in stable survivors of myocardial infarction: The CARE study. J Am Coll Cardiol. 2003;42:1446-1453.
2. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159-173. doi: 10.1161/CIRCRESAHA. 111.243162.
3. Hofmann U, Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res. 2015;116:354-367. doi: 10.1161/CIRCRESAHA.116.304072.
4. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med. 2006;203:2639-2648. doi: 10.1084/jem.20061097.
5. Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G, Kerkau T, Frantz S. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation. 2012;125:1652-1663. doi: 10.1161/CIRCULATIONAHA. 111.044164.
6. Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, Yan XX, Nie SF, Liu J, Zhou SF, Li JJ, Yao R, Liao MY, Tu X, Liao YH, Cheng X. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol. 2012;107:232. doi: 10.1007/s00395-011-0232-6.
7. Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T, Frantz S. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014;115:55-67. doi: 10.1161/CIRCRESAHA.115.303895.
8. Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012;367:2322-2333. doi: 10.1056/NEJMra1205750.
9. Eltzschig HK, Eckle T, Mager A, Küper N, Karcher C, Weissmüller T, Boengler K, Schulz R, Robson SC, Colgan SP. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res. 2006;99:1100-1108. doi: 10.1161/01. RES.0000250174.31269.70.
10. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal. 2008;1:ra6. doi: 10.1126/scisignal.1160583.
11. Zimmermann H, Zebisch M, Sträter N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 2012;8:437-502. doi: 10.1007/s11302-012-9309-4.
12. Haskó G, Linden J, Cronstein B, Pacher P. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008;7:759-770. doi: 10.1038/nrd2638.
13. Feoktistov I, Biaggioni I. Role of adenosine A(2B) receptors in inflammation. Adv Pharmacol. 2011;61:115-144. doi: 10.1016/B978-0-12-385526-8.00005-9.
14. Sun Y, Huang P. Adenosine A2B receptor: From cell biology to human diseases. Front Chem. 2016;4:37. doi: 10.3389/fchem.2016.00037.
15. Linden J. Regulation of leukocyte function by adenosine receptors. Adv Pharmacol. 2011;61:95-114. doi: 10.1016/B978-0-12-385526-8.00004-7.
16. Decking UK, Schlieper G, Kroll K, Schrader J. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res. 1997;81:154-164.
17. Man K, Kallies A. Synchronizing transcriptional control of T cell metabolism and function. Nat Rev Immunol. 2015;15:574-584. doi: 10.1038/nri3874.
18. Bönner F, Borg N, Jacoby C, Temme S, Ding Z, Flögel U, Schrader J. Ecto-5'-nucleotidase on immune cells protects from adverse cardiac remodeling. Circ Res. 2013;113:301-312. doi: 10.1161/CIRCRESAHA.113.300180.
19. Bönner F, Borg N, Burghoff S, Schrader J. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PLoS One. 2012;7:e34730. doi: 10.1371/journal. pone.0034730.
20. Koszalka P, Ozüyaman B, Huo Y, Zernecke A, Flögel U, Braun N, Buchheiser A, Decking UK, Smith ML, Sévigny J, Gear A, Weber AA, Molojavyi A, Ding Z, Weber C, Ley K, Zimmermann H, Gödecke A, Schrader J. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res. 2004;95:814-821. doi: 10.1161/01.RES.0000144796.82787.6f.
21. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation. 2007;115:1581-1590. doi: 10.1161/CIRCULATIONAHA.106.669697.
22. Smolenski RT, Lachno DR, Ledingham SJ, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr. 1990;527:414-420.
23. Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 2001;15:10-12. doi: 10.1096/fj.00-0566fje.
24. Lee SY, Fiene A, Li W, Hanck T, Brylev KA, Fedorov VE, Lecka J, Haider A, Pietzsch HJ, Zimmermann H, Sévigny J, Kortz U, Stephan H, Müller CE. Polyoxometalates: Potent and selective ecto-nucleotidase inhibitors. Biochem Pharmacol. 2015;93:171-181. doi: 10.1016/j. bcp.2014.11.002.
25. van der Hoeven D, Wan TC, Gizewski ET, Kreckler LM, Maas JE, Van Orman J, Ravid K, Auchampach JA. A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils. J Pharmacol Exp Ther. 2011;338:1004-1012. doi: 10.1124/jpet.111.181792.
26. Linden J. New insights into the regulation of inflammation by adenosine. J Clin Invest. 2006;116:1835-1837. doi: 10.1172/JCI29125.
27. Pacheco R, Martinez-Navio JM, Lejeune M, Climent N, Oliva H, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A. 2005;102:9583-9588. doi: 10.1073/pnas.0501050102.
28. Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, Fukuda K, Sano M. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24-35. doi: 10.1016/j. yjmcc.2013.04.023.
29. Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N, Frangogiannis NG. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014;307:H1233-H1242. doi: 10.1152/ajpheart. 00328.2014.
30. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163-189. doi: 10.1189/jlb.0603252.
31. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006;114:2056-2064. doi: 10.1161/CIRCULATIONAHA.106.649244.
32. Yan X, Shichita T, Katsumata Y, Matsuhashi T, Ito H, Ito K, Anzai A, Endo J, Tamura Y, Kimura K, Fujita J, Shinmura K, Shen W, Yoshimura A, Fukuda K, Sano M. Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc. 2012;1:e004408. doi: 10.1161/JAHA.112.004408.
33. Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res. 2012;95:77-85. doi: 10.1093/cvr/cvs142.
34. Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74:5-17. doi: 10.1016/j.cyto.2014.09.011.
35. Koeppen M, Harter PN, Bonney S, Bonney M, Reithel S, Zachskorn C, Mittelbronn M, Eckle T. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology. 2012;116:1245-1257. doi: 10.1097/ALN.0b013e318255793c.
36. Auchampach JA, Kreckler LM, Wan TC, Maas JE, van der Hoeven D, Gizewski E, Narayanan J, Maas GE. Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. J Pharmacol Exp Ther. 2009;329:2-13. doi: 10.1124/jpet.108.148270.
37. Németh ZH, Lutz CS, Csóka B, Deitch EA, Leibovich SJ, Gause WC, Tone M, Pacher P, Vizi ES, Haskó G. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol. 2005;175:8260-8270.
38. Csóka B, Selmeczy Z, Koscsó B, Németh ZH, Pacher P, Murray PJ, Kepka-Lenhart D, Morris SM Jr, Gause WC, Leibovich SJ, Haskó G. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 2012;26:376-386. doi: 10.1096/fj.11-190934.
39. Woehrle T, Yip L, Elkhal A, Sumi Y, Chen Y, Yao Y, Insel PA, Junger WG. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood. 2010;116:3475-3484. doi: 10.1182/blood-2010-04-277707.
40. Koch-Nolte F, Haag F, Guse AH, Lund F, Ziegler M. Emerging roles of NAD+ and its metabolites in cell signaling. Sci Signal. 2009;2:mr1. doi: 10.1126/scisignal.257mr1.
41. Hubert S, Rissiek B, Klages K, Huehn J, Sparwasser T, Haag F, Koch-Nolte F, Boyer O, Seman M, Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med. 2010;207:2561-2568. doi: 10.1084/jem.20091154.
42. Haag F, Adriouch S, Bras A, Jung C, Möller S, Scheuplein F, Bannas P, Seman M, Koch-Nolte F. Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal. 2007;3:71-81. doi: 10.1007/s11302-006-9038-7.
43. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 2006;20:2242-2250. doi: 10.1096/fj.06-6419com.
44. Wilson JM, Kurtz CC, Black SG, Ross WG, Alam MS, Linden J, Ernst PB. The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J Immunol. 2011;186:6746-6752. doi: 10.4049/jimmunol. 1100117.
45. Ryzhov S, Sung BH, Zhang Q, Weaver A, Gumina RJ, Biaggioni I, Feoktistov I. Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation. Purinergic Signal. 2014;10:477-486. doi: 10.1007/s11302-014-9410-y.
46. Toldo S, Zhong H, Mezzaroma E, Van Tassell BW, Kannan H, Zeng D, Belardinelli L, Voelkel NF, Abbate A. GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse. J Pharmacol Exp Ther. 2012;343:587-595. doi: 10.1124/jpet.111.191288.
47. Zhang H, Zhong H, Everett TH 4th, Wilson E, Chang R, Zeng D, Belardinelli L, Olgin JE. Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model. Heart Rhythm. 2014;11:101-109. doi: 10.1016/j. hrthm.2013.10.023.